Programme

Terry Kaan & Kathy Liddell

Ron Zimmern: “Health Systems and the Future of Personalized Medicine: A Population Health Perspective”

Henry T. Greely: “Precision Medicine: The Ethical, Legal, and Practical Challenges Ahead.”

Jeff Skopek: “Precision Rationing: The Law and Ethics of Differentiation.”

Ock-Joo Kim & Yoon-Jung Chang: “Precision Medicine Ethics: Prospects on Clinical Application and Ethical Issues”

Chair: Hilary Burton

I. Glenn Cohen: “Legal and Ethical Issues in Using Big Data for Predictive Analytics in Health Care.”

Terry Kaan:  “Genetic Information and the Family:  the Future of the Duty of Disclosure and the Limits of Confidentiality”

Tracey Evans Chan: “Regulatory Challenges of Innovative Therapeutics and Diagnostics in Medical Practice”

Afternoon Break

Colm McGrath: “Liability for Failure to Disclose and the Challenge of Precision Medicine”

Darrell Rowbottom: “On Probabilities in Personalised Medicine.”

Chair: Ron Zimmern

Bartha Maria Knoppers: “Activating the Right of Citizens to Benefit from Scientific Advances”

Kazuto Kato: “Genomic Medicine in Japan:  Recent Developments in National Policy, and New Ethical and Legal Challenges“

Yann  Joly: “Controlled Data Access for Precision Medicine: An Acceptable Trade-off?”

Morning Break

Alison Hall:  “Harm, Discretion or Duty: The Changing Nature of the Return of Individualised Results in Genetics Research.”

Janice Tsang: “Precision Medicine for Cancer Care – Prime Time versus Provocation Threat?”

Chair: Henry T. Greely

Donald Chalmers: “Has the Biobank Bubble Burst: A Translational Challenge?”

Kathy Liddell & John Liddicoat: “The Changing IP Landscape for Precision Medicine”.

Chih-Hsing Ho: “From Bench to Bedside: Secondary Use of Health Data for Precision Medicine“

Afternoon Break

Stuart Hogarth: “Lost on Planet Biomarker? Standards, Pathways, Carrots and Sticks for Diagnostic Development in the Post-genomic Era.”

Timo Minssen: “Lost in Translation? Opportunities & Risks of Increased Research & Clinical Trials Data Transparency”

Chair: I. Glenn Cohen

Jeffrey M. Skopek